UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013852
Receipt number R000015675
Scientific Title A phase I/II clinical trial of preoperative carbon-ion radiotherapy and concurrent chemotherapy for stage II or III squamous cell carcinoma of the thoracic esophagus
Date of disclosure of the study information 2014/04/30
Last modified on 2022/03/28 14:10:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A phase I/II clinical trial of preoperative carbon-ion radiotherapy and concurrent chemotherapy for stage II or III squamous cell carcinoma of the thoracic esophagus

Acronym

A phase I/II clinical trial of preoperative carbon-ion radiotherapy and concurrent chemotherapy for stage II or III esophageal squamous cell carcinoma

Scientific Title

A phase I/II clinical trial of preoperative carbon-ion radiotherapy and concurrent chemotherapy for stage II or III squamous cell carcinoma of the thoracic esophagus

Scientific Title:Acronym

A phase I/II clinical trial of preoperative carbon-ion radiotherapy and concurrent chemotherapy for stage II or III esophageal squamous cell carcinoma

Region

Japan


Condition

Condition

Esophageal cancer

Classification by specialty

Gastroenterology Gastrointestinal surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety and therapeutic effect of preoperative carbon-ion radiotherapy and concurrent chemotherapy for stage II or III thoracic esophageal squamous cell carcinoma

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase I,II


Assessment

Primary outcomes

Acute adverse events
Response rate

Key secondary outcomes

Late adverse events
Postoperative complications
Survival rate


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Device,equipment Maneuver

Interventions/Control_1

1.Preoperative carbon-ion radiotherapy and concurrent chemotherapy.
Carbon-ion radiotherapy is administered in 8 fractiss over 2 weeks.
Chemothrapy consists of Cisplatin 70 mg/m2/day on days 1 and 22 and 5-FU 700 mg/m2/day on days 1-4 and 22-25.
2.Eesophagectomy and LN dissection is performed within 8weeks after the completion of preoperatve treatment.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Histologically proven squamous cell carcinoma of the thoracic esophagus
2.Clinical stage II or III (sxcluding T4) according to the Japanese classification of esophageal cancer (10th edition)
3.Measurable lesion
4.Age between 20 and 75years old
5.Performance status between 0 and 2
6.Curatively resectable
7.No previous treatments for the esophageal lesion
8.Adequate organ (bone marrow, liver, kidney and so on) functions
9.Written informed consent

Key exclusion criteria

1.Past hisotry of radiotherapy in the treatment area
2.Other active cancer
3.Active interstitial pneumonia
4.Active infection in the treatment area
5.HBs-Ag positive, HCV-Ab positive, HIV-Ab positive, HTKLV-1-Ab positive

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Hitoshi
Middle name
Last name Ishikawa

Organization

National Institute for Quantum and Radiological Science and Technology

Division name

QST Hospital

Zip code

263-8555

Address

4-9-1, Anagawa, Inage-ku, Chiba

TEL

043-206-3306

Email

ishikawa.hitoshi@qst.go.jp


Public contact

Name of contact person

1st name Hitoshi
Middle name
Last name Ishikawa

Organization

National Institute for Quantum and Radiological Science and Technology

Division name

QST Hospital

Zip code

263-8555

Address

4-9-1, Anagawa, Inage-ku, Chiba

TEL

043-206-3306

Homepage URL


Email

ishikawa.hitoshi@qst.go.jp


Sponsor or person

Institute

National Institute for Quantum and Radiological Science and Technology

Institute

Department

Personal name



Funding Source

Organization

National Institute for Quantum and Radiological Science and Technology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Institutes for Quantum Science and Technology Certified Review Board

Address

4-9-1, Anagawa, Inage-ku, Chiba

Tel

043-206-4706

Email

helsinki@qst.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

QST病院


Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2012 Year 06 Month 08 Day

Date of IRB

2012 Year 06 Month 08 Day

Anticipated trial start date

2012 Year 09 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 04 Month 30 Day

Last modified on

2022 Year 03 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015675


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name